References
Alexandre J, Gross-Goupil M, Falissard B et al (2003) Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Oncol 14:36–41
Conill C, Verger E, Salamero M (1990) Performance status assessment in cancer patients. Cancer 65:1864–1866
Goldwasser F, Gross-Goupil M, Tigaud JM et al (2000) Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients. Ann Oncol 11:1463–1470
Huang PI, Chao Y, Li CP et al (2009) Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 73:159–165
Maltoni M, Pirovano M, Scarpi E et al (1995) Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 75:2613–2622
Mateus C, Lemarie E, Goldwasser F et al (2006) Prevalence of malnutrition in non-selected cancer patients: a one day survey. Ann Oncol 17(9):298
Evans WJ, Morley JE, Argiles J et al (2008) Cachexia: a new definition. Clin Nutr 27:793–799
Muscaritoli A, Anker SD, Argiles J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG), cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics. Clin Nutr 29:154–159
Sources of support
None.
Conflict of interest
None.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Cessot, A., Hebuterne, X., Coriat, R. et al. Defining the clinical condition of cancer patients: it is time to switch from performance status to nutritional status. Support Care Cancer 19, 869–870 (2011). https://doi.org/10.1007/s00520-011-1122-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1122-z